Ferron Parayre Audrey, Labrecque Michel, Rousseau Michel, Turcotte Stéphane, Légaré France
Research Centre of the Centre Hospitalier Universitaire de Québec, Hospital St-François D'Assise, Knowledge Transfer and Health Technology Assessment Research Group (AFP, ML, ST, FL).
Faculty of Medicine, Universite´ Laval, Quebec, QC, Canada (AFP, ML, FL)
Med Decis Making. 2014 Jan;34(1):54-62. doi: 10.1177/0272989X13491463. Epub 2013 Jun 17.
We sought to determine the psychometric properties of SURE, a 4-item checklist designed to screen for clinically significant decisional conflict in clinical practice.
This study was a secondary analysis of a clustered randomized trial assessing the effect of DECISION+2, a 2-hour online tutorial followed by a 2-hour interactive workshop on shared decision making, on decisions to use antibiotics for acute respiratory infections. Patients completed SURE and also the Decisional Conflict Scale (DCS), as the gold standard, after consultation. We evaluated internal consistency of SURE using the Kuder-Richardson 20 coefficient (KR-20). We compared DCS and SURE scores using the Spearman correlation coefficient. We assessed sensitivity and specificity of SURE scores (cut-off score ≤3 out of 4) by identifying patients with and without clinically significant decisional conflict (DCS score >37.5 on a scale of 0-100).
Of the 712 patients recruited during the trial, 654 completed both tools. SURE scores showed adequate internal consistency (KR-20 coefficient of 0.7). There was a significant correlation between DCS and SURE scores (Spearman's ρ = -0.45, P < 0.0001). The prevalence of clinically significant decisional conflict as estimated by the DCS was 5.2% (95% CI 3.7-7.3). Sensitivity and specificity of SURE ≤3 were 94.1% (95% CI 78.9-99.0) and 89.8% (95% CI 87.1-92.0), respectively.
SURE shows adequate psychometric properties in a primary care population with a low prevalence of clinically significant decisional conflict. SURE has the potential to be a useful screening tool for practitioners, responding to the growing need for detecting clinically significant decisional conflict in patients.
我们试图确定SURE的心理测量特性,SURE是一个包含4个条目的检查表,旨在筛查临床实践中具有临床意义的决策冲突。
本研究是一项整群随机试验的二次分析,该试验评估了DECISION+2(一个2小时在线教程,随后是一个2小时关于共同决策的互动研讨会)对急性呼吸道感染使用抗生素决策的影响。患者在咨询后完成SURE以及作为金标准的决策冲突量表(DCS)。我们使用库德-理查森20系数(KR-20)评估SURE的内部一致性。我们使用斯皮尔曼相关系数比较DCS和SURE得分。我们通过识别有无临床意义决策冲突(DCS得分在0-100量表上>37.5)来评估SURE得分(截断分数≤4分中的3分)的敏感性和特异性。
在试验期间招募的712名患者中;654名完成了这两种工具。SURE得分显示出足够的内部一致性(KR-20系数为0.7)。DCS和SURE得分之间存在显著相关性(斯皮尔曼ρ=-0.45;P<0.0001);DCS估计的具有临床意义决策冲突的患病率为5.2%(95%CI 3.7-7.3);SURE≤3的敏感性和特异性分别为94.1%(95%CI 78.9-99.0)和89.8%(95%CI 87.1-92.0)。
SURE在具有临床意义决策冲突患病率较低的初级保健人群中显示出足够的心理测量特性。SURE有可能成为从业者有用的筛查工具,满足日益增长的检测患者临床意义决策冲突的需求。